Skip to content
Tirzepatide Report
Provider review

Framework Tirzepatide Review: Price Questions & 72-Hour Renewal Rule

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Named compounded GLP-1 program with general weekly headlines and a 72-hour renewal cancellation rule.

Standout details

  • Public program names semaglutide and tirzepatide
  • Terms promise payment refund if a required prescription is not issued

Things to consider

  • General weekly GLP-1 headlines are not a selected tirzepatide bill; no confirmed current $549 quarter quote
  • $0-membership marketing and some-product subscription-fee terms require plan-specific explanation

Framework names semaglutide and tirzepatide in its compounded GLP-1 program, while its public landing pages advertise general starting rates of $25 per week and, lower on one offer page, $19 per week. Those GLP-1 headlines do not establish a selected tirzepatide price, supplied quantity or full payment schedule.3,4

Ask for the named treatment’s full charge

A weekly equivalent is not necessarily a weekly charge. Obtain the prescribed formulation, dose, supply period, first amount due and recurring bill before comparing another program’s monthly price. The public pages do not establish a current $549 three-month tirzepatide offer or a universal dose-specific monthly total.3,4

The landing page advertises $0 membership fees and doctor-guided treatment selection. Its terms say some products require a monthly auto-renewing subscription fee and authorize the selected charges. Ask whether that fee is the complete medication program charge or a separate charge, and which services, labs, supplies and shipping it covers.3,5

The terms identify Framework as a technology platform connecting patients with clinical providers and pharmacies. Provider review does not guarantee a prescription. If a prescription is required but not issued, the terms say the order is declined and the payment refunded.5

Price and program questions

ItemPublished detail
Named programSemaglutide and tirzepatide; exact prescribed preparation requires review
Public headline$25/week; $19/week also on offer page; selected tirzepatide total unconfirmed
Membership / billing$0 membership marketing; terms describe some monthly subscription products
Before paymentConfirm full first/recurring charge, supply, inclusions and accepted agreement
General GLP-1 weekly headlines do not establish the full selected tirzepatide charge or billing cadence.3,4,5

Renewal has a specific 72-hour cutoff

The terms, updated May 25, 2026, require cancellation through the patient portal at least 72 hours before the renewal charge. If that window is missed, they say the renewal payment is not refunded and the clinical visit and medication are processed as scheduled. This is more specific than a general cancel-anytime statement.5

For an initial or other order, refunds before a prescription is issued to the pharmacy or before shipping are described as discretionary, not automatic. Once the prescription is transmitted to a pharmacy or the product ships, the terms bar refunds. Confirm the order stage promptly if you need to cancel.5

The same terms broadly decline returns, exchanges or refunds for delivered, opened, used or otherwise received products. They also disclaim a refund or replacement after shipment, including for dissatisfaction or stopping treatment. Lack of results is not a stated refund basis. Ask for the applicable damaged, incorrect or lost-order remedy before purchase rather than assuming an exception.5

Cancellation and refund boundaries

ItemPublished detail
RenewalCancel via portal at least 72 hours before charge; missed window nonrefundable
No prescriptionRequired prescription not issued: order declined and payment refunded
Voluntary cancellationBefore pharmacy issue/shipping: discretionary; after transmission/shipping no refund
Received productBroad no-return/refund language; obtain delivery-problem remedy before purchase
The clinical nonapproval exception differs from discretionary voluntary cancellation and the strict renewal deadline.5

Confirm care, fulfillment and location

A public description of a compounded program does not establish the actual clinician, current credentials or the facility that will prepare and dispense your prescription. Request the responsible practice and pharmacy with the complete treatment and payment agreement. Confirm availability where you will receive care; a broad online-service description is not patient eligibility.3,5

Framework’s pages distinguish its compounded products from approved branded medicines. Brand-drug trials do not establish outcomes for the platform or its preparations. SURMOUNT-1 and SURMOUNT-5 provide clinical context, not proof that the offered formulation will produce the same results.1,2

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, FormidableMD, best tirzepatide providers.

Frequently asked questions

Is Framework tirzepatide $19 or $25 per week?

Those are general GLP-1 starting headlines on its public pages, not a selected dose-specific tirzepatide quote. Confirm the complete bill, supplied period, payment frequency, prescription and included services before comparing costs.

How do I stop a renewal charge?

The terms require cancellation through the patient portal at least 72 hours before renewal. If the cutoff is missed, the renewal payment is not refunded and processing continues. Obtain the exact renewal date and confirmation of cancellation.

Can I get a refund if treatment is declined or I change my mind?

The terms promise payment refund if a required prescription is not issued. Voluntary pre-pharmacy or pre-shipping cancellation is described as discretionary; after prescription transmission or shipment refunds are barred. Lack of results is not a stated refund basis.

References(5)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Framework (2026). Homepage: named GLP-1 program and general weekly headline. Framework.
  4. Framework (2026). GLP-1 offer landing: differing general weekly headlines. Framework.
  5. Framework (2026). Terms of service, updated May 25, 2026. Framework.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.